A new National Institute of Medicine report says that the National Cancer Institute's Cooperative Group Program — a 50-year-old program that facilitates trials of new cancer treatments — is inefficient and lacks sufficient funding to continue operations as usual.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.